Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00320_DB00932_nanopub.RACCy5gKYZbaVuS6CLxKk_zlubkver7tzvumgxa74gXLY#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00320_DB00932 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00320_DB00932 label "DDI between Dihydroergotamine and Tipranavir - Tipranavir, co-administered with Ritonavir, may increase the plasma concentration of Dihydroergotamine. Concomitant therapy is contraindicated. [drugbank_resource:DB00320_DB00932]" assertion.
- drugbank_resource:DB00320_DB00932 identifier "drugbank_resource:DB00320_DB00932" assertion.
- drugbank_resource:DB00320_DB00932 title "DDI between Dihydroergotamine and Tipranavir - Tipranavir, co-administered with Ritonavir, may increase the plasma concentration of Dihydroergotamine. Concomitant therapy is contraindicated." assertion.
- drugbank:DB00932 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00320_DB00932 assertion.
- drugbank:DB00320 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00320_DB00932 assertion.